Citations

Mayo Clinic

Showing 10 of 108522 citations.

Response to Letter Regarding Article, “Comparative Effectiveness of Carotid Revascularization Therapies: Evidence From a National Hospital Discharge Database”
McDonald, Robert J. , Cloft, Harry J. , McDonald, Jennifer S.

Stroke | December 31, 2014 | Volume: 46 | Issue: 2 | Pages: No page available

10.1161/strokeaha.114.007861 | PMID 25550376 Get It

Invited review: Frontotemporal dementia caused by microtubule‐associated protein tau gene ( MAPT ) mutation
Oblak, Adrian L. , Johnson, Keith A. , Goedert, Michel , Ghetti, Bernardino , Boeve, Bradley F. , Dickerson, Bradford Clark

Neuropathology and Applied Neurobiology | December 31, 2014 | Volume: 41 | Issue: 1 | Pages: 24-46

10.1111/nan.12213 | PMID 25556536 Get It

Hereditary frontotemporal dementia associated with mutations in the microtubule‐associated protein tau gene ( MAPT ) is a protean disorder. Three neuropathologic subtypes can be recognized, based on the presence of inclusions made of tau isoforms with three and four repeats, predominantly three repeats and mostly four repeats. This is relevant for establishing a correlation between structural magnetic resonance imaging and positron emission tomography using tracers specific for aggregated tau. Longitudinal studies will be essential to determine the evolution of anatomical alterations from the asymptomatic stage to the various phases of disease following the onset of symptoms.
Adipose tissue remodeling in a novel domestic porcine model of diet-induced obesity
Pawar, Aditya S. , Zhu, Xiang-Yang, Eirin, Alfonso , Jordan, Kyra L., Woollard, John R. , Lerman, Lilach O. , Tang, Hui Jun , Lerman, Amir , Eirin, Alfonso

Obesity | December 31, 2014 | Volume: 23 | Issue: 2 | Pages: 399-407

10.1002/oby.20971 | PMID 25627626 Get It

Ventricular Conduction and Long-Term Heart Failure Outcomes and Mortality in African Americans
Mentz, Robert J. , DeVore, Adam D. , Choudhary, Gaurav , Ahmad, Tariq , Khazanie, Prateeti , Randolph, Tiffany C., Griswold, Michael , Eapen, Zubin J., O’Brien, Emily C. , Thomas, Kevin L. , Curtis, Lesley H. , Hernandez, Adrian F. , Greiner, Melissa A, Dunlay, Shannon M. , O'Brien, Emily C, Greiner, Melissa A. , Hernandez, Adrian , Mentz, Robert J

Circulation: Heart Failure | December 31, 2014 | Volume: 8 | Issue: 2 | Pages: 243-251

10.1161/circheartfailure.114.001729 | PMID 25550439 Get It

Background— QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and mortality in African Americans. Methods and Results— We analyzed data from 5146 African Americans in the Jackson Heart Study stratified by QRS duration on baseline 12-lead ECG. We defined QRS prolongation as QRS≥100 ms. We assessed the association between QRS duration and all-cause mortality using Cox proportional hazards models and reported the cumulative incidence of heart failure hospitalization. We identified factors associated with the development of QRS prolongation in patients with normal baseline QRS. At baseline, 30% (n=1528) of participants had QRS prolongation. The cumulative incidences of mortality and heart failure hospitalization were greater with versus without baseline QRS prolongation: 12.6% (95% confidence interval [CI], 11.0–14.4) versus 7.1% (95% CI, 6.3–8.0) and 8.2% (95% CI, 6.9–9.7) versus 4.4% (95% CI, 3.7–5.1), respectively. After risk adjustment, QRS prolongation was associated with increased mortality (hazard ratio, 1.27; 95% CI, 1.03–1.56; P =0.02). There was a linear relationship between QRS duration and mortality (hazard ratio per 10 ms increase, 1.06; 95% CI, 1.01–1.12). Older age, male sex, prior myocardial infarction, lower ejection fraction, left ventricular hypertrophy, and left ventricular dilatation were associated with the development of QRS prolongation. Conclusions— QRS prolongation in African Americans was associated with increased mortality and heart failure hospitalization. Factors associated with developing QRS prolongation included age, male sex, prior myocardial infarction, and left ventricular structural abnormalities.
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
Reigstad, Christopher S., Salmonson, Charles E., Rainey, John F., Szurszewski, Joseph H., Sonnenburg, Justin L. , Farrugia, Gianrico , Kashyap, Purna , Linden, David R.

The FASEB Journal | December 30, 2014 | Volume: 29 | Issue: 4 | Pages: 1395-1403

10.1096/fj.14-259598 | PMID 25550456 Get It

Gut microbiota alterations have been described in several diseases with altered gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut microbiome in modulating GI function. Serotonin [5‐hydroxytryptamine (5‐HT)] is a key regulator of GI motility and secretion. To determine the relationship among gut microbes, colonic contractility, and host serotonergic gene expression, we evaluated mice that were germ‐free (GF) or humanized (HM; ex‐GF colonized with human gut microbiota). 5‐HT reduced contractile duration in both GF and HM colons. Microbiota from HM and conventionally raised (CR) mice significantly increased colonic mRNAs Tph1 [(tryptophan hydroxylase) 1, rate limiting for mucosal 5‐HT synthesis; P < 0.01] and chromogranin A (neuroendocrine secretion; P < 0.01), with no effect on monoamine oxidase A (serotonin catabolism), serotonin receptor 5‐HT 4 , or mouse serotonin transporter. HM and CR mice also had increased colonic Tph1 protein ( P < 0.05) and 5‐HT concentrations (GF, 17 ± 3 ng/mg; HM, 25 ± 2 ng/mg; and CR, 35 ± 3 ng/mg; P < 0.05). Enterochromaffin (EC) cell numbers (cells producing 5‐HT) were unchanged. Short‐chain fatty acids (SCFAs) promoted TPH1 transcription in BON cells (human EC cell model). Thus, gut microbiota acting through SCFAs are important determinants of enteric 5‐HT production and homeostasis.—Reigstad, C. S., Salmonson, C. E., Rainey, III, J. F., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., Kashyap, P. C. Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells. FASEB J. 29, 1395‐1403 (2015). www.fasebj.org
Sinonasal Phosphaturic Mesenchymal Tumor: Case Report and Systematic Review
Deep, Nicholas L. , Cain, Rachel B. , McCullough, Ann E. , Hoxworth, Joseph M. , Lal, Devyani

Allergy & Rhinology | December 30, 2014 | Volume: 5 | Issue: 3 | Pages: No page available

10.2500/ar.2014.5.0100 | PMID 25565053 Get It

We report a case of sinonasal phosphaturic mesenchymal tumor (PMT) and conduct a systematic review of the literature to highlight a unique paraneoplastic syndrome associated with PMT. We used English language publications from Medline and Cochrane databases (1970–2013) as data sources. A systematic review of the literature was conducted. All reported cases of head and neck PMTs were included. The presence or absence of the associated paraneoplastic syndrome was noted. We found 33 cases of PMT in the head and neck reported in the literature, 17 of which occurred in the sinonasal area. Approximately 5% of all PMTs are located in the head and neck. Just greater than half are concentrated in the sinonasal area, and the remaining involve various bony and soft tissue structures of the head and neck. PMT is sometimes associated with a paraneoplastic syndrome of tumor-induced (oncogenic) osteomalacia (TIO) causing bone pain, muscle weakness, and pathologic fractures. We present the 18th reported case of sinonasal PMT. A smooth mucosa-covered midline intraseptal mass filling the posterior nasal cavity with destruction and erosion of the skull base was found in an adult male. The patient underwent successful endoscopic resection with wide negative margins and is without recurrence at 24-month follow-up. PMT is a benign, locally aggressive tumor with rare malignant transformation. Knowledge of the bony invasion and destruction caused by this tumor is essential in planning surgical resection with wide negative margins. Familiarity with the associated TIO is essential to investigate for and manage any associated bony morbidity.
Frontotemporal dementia: a bridge between dementia and neuromuscular disease
Ng, Adeline Su Lyn , Rademakers, Rosa , Miller, Bruce L.

Annals of the New York Academy of Sciences | December 30, 2014 | Volume: 1338 | Issue: 1 | Pages: 71-93

10.1111/nyas.12638 | PMID 25557955 Get It

The concept that frontotemporal dementia (FTD) is a purely cortical dementia has largely been refuted by the recognition of its close association with motor neuron disease, and the identification of transactive response DNA‐binding protein 43 (TDP‐43) as a major pathological substrate underlying both diseases. Genetic findings have transformed this field and revealed connections between disorders that were previous thought clinically unrelated. The discovery that the C9ORF72 locus is responsible for the majority of hereditary FTD, amyotrophic lateral sclerosis (ALS), and FTD–ALS cases and the understanding that repeat‐containing RNA plays a crucial role in pathogenesis of both disorders has paved the way for the development of potential biomarkers and therapeutic targets for these devastating diseases. In this review, we summarize the historical aspects leading up to our current understanding of the genetic, clinical, and neuropathological overlap between FTD and ALS, and include brief discussions on chronic traumatic encephalopathy (CTE), given its association with TDP‐43 pathology, its associated increased dementia risk, and reports of ALS in CTE patients. In addition, we describe other genetic associations between dementia and neuromuscular disease, such as inclusion body myositis with Paget's disease and FTD.
Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?
Kang, Ningling , Shah, Vijay H. , Urrutia, Raúl

Molecular Cancer Research | December 30, 2014 | Volume: 13 | Issue: 4 | Pages: 604-612

10.1158/1541-7786.mcr-14-0542 | PMID 25548101 Get It

Abstract Cancer-associated fibroblasts (CAFs), the most abundant cells in the tumor microenvironment (TME), are a key source of the extracellular matrix (ECM) that constitutes the desmoplastic stroma. Through remodeling of the reactive tumor stroma and paracrine actions, CAFs regulate cancer initiation, progression, and metastasis, as well as tumor resistance to therapies. The CAFs found in stroma-rich primary hepatocellular carcinomas (HCC) and liver metastases of primary cancers of other organs predominantly originate from hepatic stellate cells (HSTC), which are pericytes associated with hepatic sinusoids. During tumor invasion, HSTCs transdifferentiate into myofibroblasts in response to paracrine signals emanating from either tumor cells or a heterogeneous cell population within the hepatic tumor microenvironment. Mechanistically, HSTC-to-myofibroblast transdifferentiation, also known as, HSTC activation, requires cell surface receptor activation, intracellular signal transduction, gene transcription, and epigenetic signals, which combined ultimately modulate distinct gene expression profiles that give rise to and maintain a new phenotype. The current review defines a paradigm that explains how HSTCs are activated into CAFs to promote liver metastasis. Furthermore, a focus on the most relevant intracellular signaling networks and epigenetic mechanisms that control HSTC activation is provided. Finally, we discuss the feasibility of targeting CAF/activated HSTCs, in isolation or in conjunction with targeting cancer cells, which constitutes a promising and viable therapeutic approach for the treatment of primary stroma-rich liver cancers and liver metastasis. Mol Cancer Res; 13(4); 604–12. ©2014 AACR.
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells
Zaanan, Aziz , Kawakami, Hisato , Huang, Shengbing, Okamoto, Koichi, Okamoto, Koichi , Sinicrope, Frank A.

Molecular Cancer Research | December 30, 2014 | Volume: 13 | Issue: 4 | Pages: 659-669

10.1158/1541-7786.mcr-14-0476 | PMID 25548100 Get It

Abstract KRAS mutations are frequently detected in human colorectal cancer and contribute to de novo apoptosis resistance and ultimately therapeutic failure. To overcome KRAS-mediated apoptosis resistance, the irreversible proteasome inhibitor, carfilzomib, was evaluated and found to potently induce Noxa, which was dependent upon c-Myc, and Bik. Isogenic mutant versus wild-type KRAS carcinoma cells showed elevated Bcl-xL, confirmed by KRAS siRNA or ectopic expression. Upregulated Bcl-xL by mutant KRAS was mediated by ERK as indicated by ERK knockdown. Bcl-xL expression was regulated at the level of mRNA and protein as shown using actinomycin D and cyclohexamide, respectively. Suppression of Bcl-xL by shRNA sensitized mutant KRAS cells to carfilzomib. Concurrent Bcl-xL antagonism by the BH3 mimetic ABT-263 combined with carfilzomib synergistically enhanced apoptosis that was dependent on Bax or p53, and was attenuated by Noxa or Bik shRNA. In support of this strategy, ectopically expressed Noxa enhanced apoptosis by ABT-263. Carfilzomib-induced Noxa and Bik sequestered Mcl-1 and ABT-263 released Bik and Bak from Bcl-xL, suggesting a mechanism for drug synergy. These preclinical findings establish mutant KRAS-mediated Bcl-xL upregulation as a key mechanism of apoptosis resistance in KRAS-mutant colorectal cancer. Furthermore, antagonizing Bcl-xL enabled carfilzomib-induced Noxa and Bik to induce synergistic apoptosis that reversed KRAS-mediated resistance. Implications: This novel study reveals a promising treatment strategy to overcome apoptosis resistance in KRAS-mutant colorectal cancer by concurrent upregulation of Noxa/Bik and antagonism of Bcl-xL. Mol Cancer Res; 13(4); 659–69. ©2014 AACR.
Acupuncture Treatment of Diplopia Associated with Abducens Palsy: A Case Report
Do, Alexander , Wahner‐Roedler, Dietlind L. , Bauer, Brent A.

Global Advances in Health and Medicine | December 30, 2014 | Volume: 3 | Issue: 4 | Pages: 32-34

10.7453/gahmj.2014.024 | PMID 25105074 Get It

Abducens palsy (ie, sixth nerve palsy) is the most common single extraocular muscle palsy. The primary symptom is double vision. The treatment goal is to correct the underlying cause. If no cause is identified or the palsy is related to a well-managed chronic disease, treatment consists of patching one eye or applying a temporary prism. We report a patient whose abducens palsy resolved with four acupuncture treatments. The patient, a 58-year-old Vietnamese man with diabetes mellitus, presented to our institution's ophthalmology department with sudden onset of double vision. Ophthalmologic examination resulted in diagnosis of isolated left abducens palsy. The patient received a temporary prism for symptomatic relief. With no improvement after 2 months, he presented to our integrative medicine program inquiring about acupuncture. He received four acupuncture treatments over 11 weeks with complete resolution of his diplopia. This case is suggestive that acupuncture may be helpful treatment of patients with abducens palsy.